Changes in direct-to-consumer pharmaceutical advertising following shifts from prescription-only to over-the-counter status

JAMA. 2012 Sep 12;308(10):973-5. doi: 10.1001/2012.jama.10647.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Advertising / standards*
  • Advertising / trends
  • Contraindications
  • Drug Industry
  • Drugs, Generic
  • Humans
  • Nonprescription Drugs* / adverse effects
  • Prescription Drugs* / adverse effects
  • Terminology as Topic
  • United States
  • United States Federal Trade Commission
  • United States Food and Drug Administration

Substances

  • Drugs, Generic
  • Nonprescription Drugs
  • Prescription Drugs